Brookdale Senior Living (BKD) Financials

$6.48 -0.09 (-1.30%)

As of 12:54 PM Eastern

Annual Income Statements for Brookdale Senior Living

This table shows Brookdale Senior Living's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Income / (Loss) Attributable to Common Shareholders	-202	-189	-238	-99	82	-268	-528	-571	-404	-457	-150
Consolidated Net Income / (Loss)	-202	-189	-238	-99	82	-268	-528	-572	-405	-458	-149
Net Income / (Loss) Continuing Operations	-202	-189	-238	-99	82	-268	-528	-572	-405	-458	-149
Total Pre-Tax Income	-197	-180	-240	-108	87	-271	-578	-588	-399	-550	-331
Total Operating Income	47	18	-43	-217	-98	-44	-594	-270	-31	-165	-85
Total Gross Profit	2,983	2,877	2,678	327	797	607	765	914	1,440	1,448	1,133
Total Revenue	3,125	3,016	2,825	2,758	3,540	4,057	4,531	4,747	4,977	4,961	3,832
Operating Revenue	3,125	3,016	2,825	2,758	3,540	4,057	4,531	4,747	4,977	4,961	3,832
Total Cost of Revenue	143	139	147	2,432	2,743	3,450	3,767	3,833	3,537	3,512	2,699
Operating Cost of Revenue	143	139	147	2,432	2,743	3,450	3,767	3,833	3,537	3,512	2,699
Total Operating Expenses	2,936	2,858	2,721	544	895	651	1,359	1,184	1,471	1,614	1,218
Selling, General & Admin Expense	2,369	2,309	2,252	185	207	219	259	278	313	371	280
Depreciation Expense	358	343	347	338	359	379	447	482	520	733	537
Other Operating Expenses / (Income)	201	202	165	-2.00	224	-	162	-	374	368	324
Impairment Charge	8.56	41	30	23	107	49	490	410	249	58	9.99
Other Special Charges / (Income)	0.00	-36	-74	0.00	-2.30	3.39	-	14	11	76	0.00
Total Other Income / (Expense), net	-244	-199	-197	109	185	-226	16	-318	-368	-385	-246
Interest Expense	274	242	214	197	198	254	292	338	395	395	252
Interest & Investment Income	19	19	-3.85	12	2.69	5.32	1.04	-10	4.59	0.80	1.51
Other Income / (Expense), net	11	24	20	295	380	22	307	31	22	9.03	4.08
Income Tax Expense	4.65	8.78	-1.56	-8.16	5.35	-2.27	-49	-17	5.38	-92	-181
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.06	-0.06	0.09	-0.07	-0.07	-0.56	-0.09	-0.19	-0.24	-0.68	0.44
Basic Earnings per Share	($0.89)	($0.84)	($1.25)	($0.54)	$0.45	($1.44)	($2.82)	($3.07)	($2.18)	($2.48)	($1.01)
Weighted Average Basic Shares Outstanding	227.53M	225.21M	190.46M	184.98M	183.50M	185.91M	187.47M	186.16M	185.65M	184.33M	148.19M
Diluted Earnings per Share	($0.89)	($0.84)	($1.25)	($0.54)	$0.44	($1.44)	($2.82)	($3.07)	($2.18)	($2.48)	($1.01)
Weighted Average Diluted Shares Outstanding	227.53M	225.21M	190.46M	184.98M	184.39M	185.91M	187.47M	186.16M	185.65M	184.33M	148.19M
Weighted Average Basic & Diluted Shares Outstanding	200.19M	189.34M	187.20M	185.58M	183.46M	185.91M	187.47M	186.16M	185.65M	184.33M	148.19M

This table shows Brookdale Senior Living's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-65	-84	-51	-38	-30	-91	-49	-4.51	-45	-26	-28
Consolidated Net Income / (Loss)	-65	-84	-51	-38	-30	-91	-49	-4.53	-45	-26	-28
Net Income / (Loss) Continuing Operations	-65	-84	-51	-38	-30	-91	-49	-4.53	-45	-26	-28
Total Pre-Tax Income	-66	-80	-50	-37	-30	-81	-51	-4.25	-44	-26	-29
Total Operating Income	30	-2.14	10	19	19	-24	-6.34	41	7.82	26	19
Total Gross Profit	780	2,375	198	205	204	2,318	185	186	188	2,259	194
Total Revenue	814	781	784	778	783	754	757	751	753	701	757
Operating Revenue	814	781	784	778	783	754	757	751	753	701	757
Total Cost of Revenue	34	-1,594	586	573	579	-1,564	572	565	566	-1,558	563
Operating Cost of Revenue	34	-1,594	586	573	579	-1,564	572	565	566	-1,558	563
Total Operating Expenses	750	2,377	188	186	185	2,343	191	145	180	2,233	175
Selling, General & Admin Expense	605	2,232	45	47	46	2,172	43	45	49	2,124	41
Depreciation Expense	91	94	90	88	86	87	86	84	85	88	87
Other Operating Expenses / (Income)	53	46	52	51	51	53	53	51	46	-	41
Impairment Charge	1.79	5.92	0.93	0.00	1.71	31	9.09	0.52	0.00	12	5.69
Total Other Income / (Expense), net	-95	-78	-60	-56	-49	-57	-44	-45	-52	-52	-48
Interest Expense	99	88	64	61	61	63	60	60	59	63	55
Interest & Investment Income	3.65	5.01	4.66	4.71	4.78	4.54	4.90	4.96	4.75	2.44	0.17
Other Income / (Expense), net	0.22	4.69	-1.14	0.05	7.13	1.77	11	9.23	2.25	8.45	6.72
Income Tax Expense	-0.68	3.56	0.68	0.45	-0.04	9.81	-1.88	0.28	0.57	-0.47	-0.30
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.01	-0.02	-0.01	-0.02	-0.02	-0.01	-0.02	-0.02	-0.01	-0.01	-0.02
Basic Earnings per Share	($0.28)	($0.37)	($0.22)	($0.17)	($0.13)	($0.40)	($0.22)	($0.02)	($0.20)	($0.11)	($0.15)
Weighted Average Basic Shares Outstanding	230.68M	227.53M	228.12M	226.79M	225.89M	225.21M	225.42M	225.40M	224.58M	190.46M	186.79M
Diluted Earnings per Share	($0.28)	($0.37)	($0.22)	($0.17)	($0.13)	($0.40)	($0.22)	($0.02)	($0.20)	($0.11)	($0.15)
Weighted Average Diluted Shares Outstanding	230.68M	227.53M	228.12M	226.79M	225.89M	225.21M	225.42M	225.40M	224.58M	190.46M	186.79M
Weighted Average Basic & Diluted Shares Outstanding	234.35M	200.19M	199.21M	197.20M	193.01M	189.34M	188.24M	188.22M	188.21M	187.20M	186.81M

This table details how cash moves in and out of Brookdale Senior Living's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Change in Cash & Equivalents	30	-125	36	-27	163	-149	168	5.22	123	-16	46
Net Cash From Operating Activities	166	163	3.28	-95	206	216	204	378	374	292	243
Net Cash From Continuing Operating Activities	166	163	3.28	-95	206	216	204	378	374	292	177
Net Income / (Loss) Continuing Operations	-202	-189	-238	-99	82	-268	-528	-572	-405	-458	-149
Consolidated Net Income / (Loss)	-202	-189	-238	-99	82	-268	-528	-572	-405	-458	-149
Depreciation Expense	368	350	354	345	365	384	456	495	530	737	545
Amortization Expense	0.00	-0.73	-2.31	-1.76	-2.12	-1.63	4.87	13	22	12	4.83
Non-Cash Adjustments To Reconcile Net Income	-15	-46	-67	-278	-395	56	329	444	303	111	79
Changes in Operating Assets and Liabilities, net	16	48	-43	-60	155	47	-58	-2.19	-77	-109	-236
Net Cash From Investing Activities	-278	-113	-67	181	-425	-226	289	-602	172	-569	-315
Net Cash From Continuing Investing Activities	-278	-113	-67	181	-425	-226	289	-602	172	-569	-315
Purchase of Property, Plant & Equipment	-310	-234	-203	-177	-658	-305	-497	-219	-346	-411	-304
Acquisitions	0.00	-7.59	-0.22	-5.44	-4.08	-4.35	-9.12	-199	-13	-261	-67
Purchase of Investments	-59	-187	-265	-362	-378	-186	-15	-341	0.00	0.00	-
Sale of Property, Plant & Equipment	7.02	84	4.65	334	331	93	500	71	298	49	4.34
Sale and/or Maturity of Investments	81	207	401	390	280	178	309	80	219	9.05	12
Other Investing Activities, net	3.22	24	-4.14	1.70	3.57	-0.86	1.16	6.44	14	44	11
Net Cash From Financing Activities	142	-174	100	-114	383	-139	-325	229	-422	261	118
Net Cash From Continuing Financing Activities	142	-174	100	-114	383	-139	-325	229	-422	261	118
Repayment of Debt	-620	-378	-289	-446	-724	-434	-1,113	-1,171	-2,067	-1,500	-978
Issuance of Debt	766	206	254	353	1,129	322	808	1,409	1,666	1,763	771
Issuance of Common Equity	0.00	0.00	139	0.00	0.00	-	-	-	-	-	330
Other Financing Activities, net	-3.44	-1.92	-4.29	-21	-4.04	-3.31	-16	-8.62	-12	-2.47	-5.52

This table details how cash moves in and out of Brookdale Senior Living's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-64	48	-30	-33	46	-54	-5.31	-28	-38	80	66
Net Cash From Operating Activities	23	45	66	56	-1.15	29	46	64	24	-49	64
Net Cash From Continuing Operating Activities	23	45	66	56	-1.15	29	46	64	24	-49	64
Net Income / (Loss) Continuing Operations	-65	-84	-51	-38	-30	-91	-49	-4.53	-45	-26	-28
Consolidated Net Income / (Loss)	-65	-84	-51	-38	-30	-91	-49	-4.53	-45	-26	-28
Depreciation Expense	95	96	92	90	88	89	88	86	87	90	88
Non-Cash Adjustments To Reconcile Net Income	37	14	-4.75	-9.42	-15	24	-9.03	-35	-26	-72	-2.86
Changes in Operating Assets and Liabilities, net	-43	19	30	12	-45	6.98	16	17	8.49	-41	6.86
Net Cash From Investing Activities	-327	-145	-58	-68	-6.95	22	-32	-42	-62	-9.94	23
Net Cash From Continuing Investing Activities	-327	-145	-58	-68	-6.95	22	-32	-42	-62	-9.94	23
Purchase of Property, Plant & Equipment	-353	-159	-55	-52	-44	-59	-65	-61	-50	-46	-54
Purchase of Investments	-2.17	-11	-20	-27	-0.63	-20	-53	-64	-50	-35	-25
Sale of Property, Plant & Equipment	0.00	-	-	6.17	0.85	40	0.12	43	0.00	-1.19	0.11
Sale and/or Maturity of Investments	22	26	16	4.47	35	55	83	37	31	77	101
Other Investing Activities, net	6.36	-0.84	1.53	-0.05	2.57	5.05	11	2.33	6.36	-3.91	-0.38
Net Cash From Financing Activities	240	147	-39	-20	54	-105	-19	-50	0.17	138	-20
Net Cash From Continuing Financing Activities	240	147	-39	-20	54	-105	-19	-50	0.17	138	-20
Repayment of Debt	-76	-354	-222	-21	-23	-285	-19	-50	-24	-223	-22
Issuance of Debt	321	502	183	0.35	81	180	-	0.01	26	222	2.73
Other Financing Activities, net	-4.76	-0.01	-0.02	-0.01	-3.40	-0.04	-0.02	-0.18	-1.68	-0.01	-0.09

This table presents Brookdale Senior Living's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Total Assets	6,336	5,573	5,937	6,410	6,902	7,194	6,467	7,675	9,218	10,049	10,417
Total Current Assets	513	478	637	699	774	596	774	902	620	498	531
Cash & Equivalents	309	278	399	347	380	240	398	223	216	88	104
Restricted Cash	40	41	28	27	28	27	28	37	33	33	39
Short-Term Investments	20	30	49	182	173	69	15	292	0.00	-	-
Accounts Receivable	52	48	56	51	109	134	134	129	142	144	150
Prepaid Expenses	92	81	106	88	67	84	106	115	131	123	238
Plant, Property, & Equipment, net	4,594	4,331	4,536	4,904	0.00	0.00	0.00	5,852	7,379	8,031	8,390
Total Noncurrent Assets	1,228	764	764	807	6,128	6,598	5,693	921	1,219	1,519	1,497
Goodwill	27	27	27	27	154	154	154	506	705	726	737
Other Noncurrent Operating Assets	1,170	707	632	648	844	1,278	5,436	195	235	259	236
Other Noncurrent Nonoperating Assets	31	30	48	64	57	35	24	23	28	33	56
Total Liabilities & Shareholders' Equity	6,336	5,573	5,937	6,410	6,902	7,194	6,467	7,675	9,218	10,049	10,417
Total Liabilities	6,122	5,168	5,353	5,711	6,099	6,496	5,449	6,145	7,140	7,590	7,535
Total Current Liabilities	580	600	641	632	691	1,047	773	1,096	731	840	874
Short-Term Debt	152	234	243	212	69	339	294	603	215	236	268
Accounts Payable	66	67	71	76	71	105	95	92	77	128	76
Accrued Expenses	264	243	237	255	288	267	298	330	328	373	423
Current Deferred Revenue	61	56	66	67	97	79	62	68	107	99	102
Other Current Liabilities	37	1.08	24	22	166	257	23	-	-	-	-
Total Noncurrent Liabilities	5,542	4,568	4,712	5,079	5,408	5,449	4,676	5,049	6,409	6,750	6,661
Long-Term Debt	4,022	3,656	3,784	3,778	3,847	3,216	3,346	3,375	3,414	3,769	3,441
Capital Lease Obligations	267	151	225	532	544	771	851	1,164	2,416	2,427	2,537
Noncurrent Deferred & Payable Income Tax Liabilities	9.60	5.99	0.00	-	9.56	15	18	71	81	69	159
Other Noncurrent Operating Liabilities	1,243	756	703	769	1,008	1,446	197	215	231	217	268
Total Equity & Noncontrolling Interests	214	405	584	700	803	699	1,018	1,530	2,078	2,459	2,882
Total Preferred & Common Equity	212	404	583	697	800	696	1,019	1,531	2,078	2,459	2,882
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	212	404	583	697	800	696	1,019	1,531	2,078	2,459	2,882
Common Stock	4,355	4,344	4,334	4,211	4,214	4,174	4,153	4,128	4,104	4,071	4,037
Retained Earnings	-4,040	-3,838	-3,649	-3,410	-3,311	-3,393	-3,069	-2,541	-1,970	-1,565	-1,108
Treasury Stock	-103	-103	-103	-103	-103	-85	-65	-56	-56	-47	-47
Noncontrolling Interest	1.43	1.49	1.55	2.22	2.30	2.37	-0.49	-0.44	-0.25	-0.16	0.52

This table presents Brookdale Senior Living's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	6,206	5,939	5,451	5,542	5,829	5,905	5,886	6,094
Total Current Assets	454	474	493	516	594	617	666	581
Cash & Equivalents	240	255	290	319	332	337	362	299
Restricted Cash	38	49	44	46	41	35	29	37
Short-Term Investments	0.00	30	20	0.00	66	96	69	90
Accounts Receivable	58	53	50	50	48	48	53	52
Prepaid Expenses	118	87	89	102	95	101	130	104
Plant, Property, & Equipment, net	4,546	4,641	4,256	4,294	4,372	4,428	4,493	4,802
Total Noncurrent Assets	1,206	824	702	733	863	859	726	711
Goodwill	27	27	27	27	27	27	27	27
Other Noncurrent Operating Assets	1,140	769	646	674	746	744	598	565
Other Noncurrent Nonoperating Assets	38	28	29	31	30	37	45	58
Total Liabilities & Shareholders' Equity	6,206	5,939	5,451	5,542	5,829	5,905	5,886	6,094
Total Liabilities	6,058	5,645	5,109	5,167	5,336	5,365	5,345	5,601
Total Current Liabilities	556	584	622	614	898	649	707	657
Short-Term Debt	166	202	260	262	495	242	266	220
Accounts Payable	73	73	75	74	77	95	89	78
Accrued Expenses	250	249	232	218	260	242	238	262
Current Deferred Revenue	66	59	54	58	65	69	70	74
Other Current Liabilities	1.23	1.16	1.12	1.10	1.03	1.00	25	24
Total Noncurrent Liabilities	5,502	5,061	4,487	4,553	4,437	4,716	4,638	4,944
Long-Term Debt	4,248	3,654	3,679	3,692	3,493	3,761	3,772	3,759
Capital Lease Obligations	25	603	150	150	151	151	218	523
Noncurrent Deferred & Payable Income Tax Liabilities	8.45	5.94	5.63	5.56	-	-	-	-
Other Noncurrent Operating Liabilities	1,220	798	652	704	794	805	647	662
Total Equity & Noncontrolling Interests	148	294	342	375	493	539	541	493
Total Preferred & Common Equity	147	293	340	374	492	538	539	491
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	147	293	340	374	492	538	539	491
Common Stock	4,354	4,352	4,348	4,344	4,341	4,338	4,336	4,217
Retained Earnings	-4,105	-3,956	-3,905	-3,867	-3,747	-3,698	-3,693	-3,623
Treasury Stock	-103	-103	-103	-103	-103	-103	-103	-103
Noncontrolling Interest	1.42	1.45	1.46	1.47	1.50	1.52	1.53	1.56

This table displays calculated financial ratios and metrics derived from Brookdale Senior Living's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	3.64%	6.74%	2.43%	-22.09%	-12.74%	-10.47%	-4.54%	-4.62%	0.33%	29.46%	32.49%
EBITDA Growth	8.26%	19.16%	-21.75%	-34.82%	79.53%	107.16%	-35.38%	-50.50%	-8.37%	26.42%	12.51%
EBIT Growth	34.15%	291.25%	-128.74%	-72.49%	1,355.17%	92.16%	-19.78%	-2,491.73%	94.08%	-93.22%	-159.88%
NOPAT Growth	152.70%	143.13%	80.32%	-65.60%	-194.40%	92.51%	-120.06%	-768.79%	81.19%	-94.58%	-164.67%
Net Income Growth	-6.84%	20.67%	-139.87%	-221.26%	130.52%	49.18%	7.57%	-41.26%	11.68%	-206.61%	-4,069.25%
EPS Growth	-5.95%	32.80%	-131.48%	-222.73%	130.56%	48.94%	8.14%	-40.83%	12.10%	-145.54%	-3,266.67%
Operating Cash Flow Growth	2.00%	4,865.65%	103.47%	-146.02%	-4.97%	6.10%	-46.09%	1.26%	27.80%	20.49%	-33.72%
Free Cash Flow Firm Growth	-176.55%	-16.04%	410.21%	24.81%	-134.46%	-42.14%	-65.87%	134.05%	165.86%	104.71%	-5,180.99%
Invested Capital Growth	4.64%	-4.48%	-6.02%	-1.60%	0.27%	-6.76%	-16.00%	-22.66%	-8.18%	-4.19%	149.09%
Revenue Q/Q Growth	0.85%	1.82%	2.05%	-7.02%	-3.66%	-1.99%	-35.20%	95.71%	-0.54%	-0.33%	15.63%
EBITDA Q/Q Growth	8.16%	-12.65%	38.09%	-12.80%	5.35%	-38.03%	276.21%	211.46%	-21.89%	-3.59%	10.31%
EBIT Q/Q Growth	77.61%	-57.01%	79.76%	-43.54%	16.44%	-111.98%	34.18%	45.13%	-106.04%	29.58%	-437.07%
NOPAT Q/Q Growth	90.45%	-73.06%	65.12%	-35.21%	25.39%	6.92%	-9.00%	40.13%	-122.46%	28.43%	-529.01%
Net Income Q/Q Growth	3.46%	-53.03%	19.04%	-60.83%	135.74%	-488.31%	-193.20%	56.69%	-30.39%	-17.28%	-242.68%
EPS Q/Q Growth	3.26%	-52.73%	18.30%	-42.11%	144.44%	-500.00%	18.26%	33.26%	-30.54%	-9.25%	-248.28%
Operating Cash Flow Q/Q Growth	10.58%	91.52%	111.11%	-257.06%	-6.62%	33.77%	-19.87%	-3.16%	1.68%	1.52%	-11.41%
Free Cash Flow Firm Q/Q Growth	41.89%	-48.22%	226.73%	-135.52%	-107.33%	125.09%	-24.92%	5.02%	-18.92%	341.34%	0.10%
Invested Capital Q/Q Growth	-3.12%	-0.98%	-4.38%	4.22%	-1.61%	-26.20%	-2.51%	-4.33%	-4.04%	-4.10%	-0.59%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	95.43%	95.38%	94.78%	11.84%	22.52%	14.96%	16.87%	19.26%	28.93%	29.20%	29.57%
EBITDA Margin	13.59%	13.01%	11.65%	15.26%	18.24%	8.86%	3.83%	5.66%	10.90%	11.94%	12.23%
Operating Margin	1.49%	0.61%	-1.51%	-7.87%	-2.76%	-1.10%	-13.11%	-5.69%	-0.62%	-3.33%	-2.22%
EBIT Margin	1.83%	1.42%	-0.79%	2.82%	7.97%	-0.55%	-6.33%	-5.05%	-0.19%	-3.15%	-2.11%
Profit (Net Income) Margin	-6.46%	-6.27%	-8.44%	-3.60%	2.31%	-6.62%	-11.66%	-12.04%	-8.13%	-9.24%	-3.90%
Tax Burden Percent	102.35%	104.87%	99.35%	92.41%	93.87%	99.16%	91.44%	97.19%	101.35%	83.25%	45.18%
Interest Burden Percent	-344.65%	-422.37%	1,074.86%	-138.48%	30.93%	1,204.02%	201.39%	245.53%	4,320.04%	352.40%	409.18%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	6.13%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.78%	0.31%	-0.68%	-3.33%	-1.99%	-0.65%	-7.71%	-2.81%	-0.27%	-1.37%	-0.98%
ROIC Less NNEP Spread (ROIC-NNEP)	-5.31%	-5.20%	-6.24%	-1.95%	2.52%	-6.74%	-10.44%	-10.59%	-7.05%	-7.31%	-3.19%
Return on Net Nonoperating Assets (RNNOA)	-66.04%	-38.53%	-36.45%	-9.90%	12.91%	-30.62%	-33.75%	-28.87%	-17.56%	-15.79%	-6.67%
Return on Equity (ROE)	-65.26%	-38.22%	-37.13%	-13.23%	10.92%	-31.27%	-41.46%	-31.69%	-17.84%	-17.16%	-7.66%
Cash Return on Invested Capital (CROIC)	-3.75%	4.90%	5.52%	-1.71%	-2.26%	6.35%	9.68%	22.75%	8.25%	2.91%	-86.40%
Operating Return on Assets (OROA)	0.96%	0.74%	-0.36%	1.17%	4.00%	-0.33%	-4.06%	-2.84%	-0.10%	-1.53%	-1.07%
Return on Assets (ROA)	-3.39%	-3.29%	-3.86%	-1.49%	1.16%	-3.93%	-7.47%	-6.77%	-4.20%	-4.48%	-1.97%
Return on Common Equity (ROCE)	-64.95%	-38.11%	-37.02%	-13.19%	10.88%	-31.24%	-41.48%	-31.69%	-17.84%	-17.16%	-7.66%
Return on Equity Simple (ROE_SIMPLE)	-95.07%	-46.84%	-40.91%	-14.25%	10.24%	-38.56%	-51.86%	-37.34%	-19.47%	-18.63%	-5.19%
Net Operating Profit after Tax (NOPAT)	33	13	-30	-152	-92	-31	-416	-189	-22	-116	-59
NOPAT Margin	1.04%	0.43%	-1.06%	-5.51%	-2.59%	-0.77%	-9.18%	-3.98%	-0.44%	-2.33%	-1.55%
Net Nonoperating Expense Percent (NNEP)	6.09%	5.51%	5.56%	-1.38%	-4.51%	6.09%	2.73%	7.78%	6.78%	5.94%	2.20%
Return On Investment Capital (ROIC_SIMPLE)	0.70%	0.29%	-0.62%	-	-	-	-	-	-	-	-
Cost of Revenue to Revenue	4.57%	4.62%	5.22%	88.16%	77.48%	85.04%	83.13%	80.74%	71.07%	70.80%	70.43%
SG&A Expenses to Revenue	75.80%	76.55%	79.71%	6.70%	5.84%	5.41%	5.73%	5.86%	6.30%	7.47%	7.31%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	93.94%	94.77%	96.30%	19.71%	25.28%	16.06%	29.99%	24.94%	29.56%	32.53%	31.79%
Earnings before Interest and Taxes (EBIT)	57	43	-22	78	282	-22	-287	-240	-9.24	-156	-81
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	425	392	329	421	646	360	174	269	543	592	469
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.72	2.71	0.88	1.37	1.01	1.94	1.23	1.18	1.11	1.39	2.33
Price to Tangible Book Value (P/TBV)	5.41	2.91	0.92	1.43	1.26	2.49	1.55	1.89	1.79	2.13	3.38
Price to Revenue (P/Rev)	0.32	0.36	0.18	0.35	0.23	0.33	0.28	0.38	0.46	0.69	1.76
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	9.91	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	10.10%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.19	1.18	0.99	1.07	1.02	1.16	1.07	1.07	1.05	1.13	1.45
Enterprise Value to Revenue (EV/Rev)	1.62	1.59	1.50	1.76	1.32	1.31	1.17	1.32	1.60	1.89	3.27
Enterprise Value to EBITDA (EV/EBITDA)	11.95	12.20	12.85	11.54	7.26	14.80	30.42	23.34	14.63	15.79	26.72
Enterprise Value to EBIT (EV/EBIT)	88.64	112.19	0.00	62.55	16.61	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	155.84	371.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	30.54	29.39	1,290.04	0.00	22.80	24.59	25.89	16.57	21.25	31.98	51.58
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	23.50	17.44	0.00	0.00	17.62	10.12	4.10	12.15	38.06	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	20.76	9.97	7.28	6.46	5.56	6.19	4.41	3.36	2.91	2.62	2.17
Long-Term Debt to Equity	20.05	9.40	6.86	6.16	5.47	5.71	4.12	2.97	2.81	2.52	2.07
Financial Leverage	12.44	7.41	5.84	5.08	5.12	4.54	3.23	2.73	2.49	2.16	2.09
Leverage Ratio	19.24	11.63	9.62	8.86	9.39	7.96	5.55	4.68	4.25	3.83	3.88
Compound Leverage Factor	-66.30	-49.14	103.38	-12.27	2.90	95.79	11.18	11.50	183.47	13.50	15.89
Debt to Total Capital	95.40%	90.89%	87.92%	86.60%	84.75%	86.10%	81.52%	77.07%	74.42%	72.35%	68.43%
Short-Term Debt to Total Capital	3.26%	5.27%	5.02%	4.06%	1.31%	6.75%	5.34%	9.03%	2.65%	2.65%	2.94%
Long-Term Debt to Total Capital	92.14%	85.62%	82.90%	82.55%	83.44%	79.34%	76.17%	68.04%	71.77%	69.70%	65.49%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.03%	0.03%	0.03%	0.04%	0.04%	0.05%	-0.01%	-0.01%	0.00%	0.00%	0.01%
Common Equity to Total Capital	4.56%	9.08%	12.05%	13.36%	15.21%	13.86%	18.49%	22.94%	25.58%	27.66%	31.57%
Debt to EBITDA	10.45	10.30	12.91	10.75	6.91	12.03	25.88	19.14	11.14	10.86	13.33
Net Debt to EBITDA	9.59	9.41	11.30	9.26	6.00	11.04	23.18	16.61	10.37	10.03	12.36
Long-Term Debt to EBITDA	10.10	9.70	12.18	10.24	6.80	11.09	24.18	16.90	10.74	10.46	12.76
Debt to NOPAT	136.35	313.52	-142.29	-29.78	-48.63	-138.90	-10.80	-27.20	-277.84	-55.62	-105.10
Net Debt to NOPAT	125.03	286.43	-124.53	-25.67	-42.24	-127.44	-9.67	-23.60	-258.67	-51.37	-97.43
Long-Term Debt to NOPAT	131.68	295.35	-134.16	-28.38	-47.88	-128.00	-10.09	-24.02	-267.94	-53.59	-100.58
Altman Z-Score	-0.28	-0.30	-0.34	-0.16	0.07	-0.06	0.03	0.20	0.42	0.45	0.69
Noncontrolling Interest Sharing Ratio	0.47%	0.31%	0.29%	0.30%	0.31%	0.11%	-0.04%	-0.02%	-0.01%	0.01%	0.01%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.88	0.80	0.99	1.11	1.12	0.57	1.00	0.82	0.85	0.59	0.61
Quick Ratio	0.66	0.59	0.78	0.92	0.96	0.42	0.71	0.59	0.49	0.28	0.29
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-156	204	243	-78	-104	302	522	1,529	653	246	-5,217
Operating Cash Flow to CapEx	54.91%	108.43%	1.65%	0.00%	62.94%	102.15%	0.00%	254.66%	780.52%	80.80%	80.91%
Free Cash Flow to Firm to Interest Expense	-0.57	0.84	1.14	-0.40	-0.53	1.19	1.79	4.52	1.66	0.62	-20.71
Operating Cash Flow to Interest Expense	0.61	0.67	0.02	-0.48	1.04	0.85	0.70	1.12	0.95	0.74	0.96
Operating Cash Flow Less CapEx to Interest Expense	-0.50	0.05	-0.91	0.32	-0.61	0.02	0.71	0.68	0.83	-0.18	-0.23
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.52	0.52	0.46	0.41	0.50	0.59	0.64	0.56	0.52	0.48	0.51
Accounts Receivable Turnover	62.33	57.91	52.86	34.40	29.16	30.33	34.48	35.08	34.83	33.77	30.17
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.70	0.68	0.60	0.00	0.00	0.00	0.00	0.72	0.65	0.60	0.62
Accounts Payable Turnover	2.16	2.03	2.00	33.00	31.18	34.54	40.31	45.31	34.45	34.38	37.97
Days Sales Outstanding (DSO)	5.86	6.30	6.90	10.61	12.52	12.03	10.59	10.41	10.48	10.81	12.10
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	168.61	180.14	182.21	11.06	11.71	10.57	9.05	8.06	10.60	10.62	9.61
Cash Conversion Cycle (CCC)	-162.76	-173.84	-175.30	-0.45	0.81	1.47	1.53	2.35	-0.12	0.19	2.48
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	4,255	4,066	4,257	4,530	4,603	4,591	4,924	5,862	7,580	8,255	8,616
Invested Capital Turnover	0.75	0.72	0.64	0.60	0.77	0.85	0.84	0.71	0.63	0.59	0.63
Increase / (Decrease) in Invested Capital	189	-191	-273	-74	12	-333	-938	-1,718	-675	-361	5,157
Enterprise Value (EV)	5,076	4,789	4,233	4,857	4,688	5,321	5,281	6,268	7,939	9,351	12,517
Market Capitalization	1,002	1,096	510	956	812	1,349	1,258	1,808	2,311	3,411	6,726
Book Value per Share	$1.07	$2.14	$3.12	$3.76	$4.36	$3.75	$5.43	$8.21	$11.17	$13.31	$15.71
Tangible Book Value per Share	$0.93	$2.00	$2.97	$3.62	$3.52	$2.92	$4.33	$5.13	$6.93	$8.68	$10.85
Total Capital	4,655	4,446	4,836	5,222	5,262	5,025	5,510	6,673	8,123	8,891	9,128
Total Debt	4,441	4,041	4,252	4,522	4,460	4,327	4,492	5,142	6,045	6,432	6,246
Total Long-Term Debt	4,289	3,807	4,009	4,310	4,391	3,987	4,197	4,540	5,830	6,197	5,978
Net Debt	4,072	3,692	3,721	3,898	3,873	3,970	4,023	4,461	5,628	5,940	5,790
Capital Expenditures (CapEx)	303	150	198	-157	327	212	-2.56	149	48	362	300
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-284	-237	-237	-277	-430	-447	-146	-143	-146	-227	-218
Debt-free Net Working Capital (DFNWC)	85	112	239	279	152	-111	295	409	104	-107	-75
Net Working Capital (NWC)	-67	-122	-4.11	67	83	-451	0.69	-194	-112	-342	-343
Net Nonoperating Expense (NNE)	235	202	208	-52	-174	237	112	383	383	343	90
Net Nonoperating Obligations (NNO)	4,041	3,661	3,673	3,830	3,801	3,892	3,906	4,332	5,502	5,796	5,734
Total Depreciation and Amortization (D&A)	368	350	352	343	363	382	460	508	552	748	549
Debt-free, Cash-free Net Working Capital to Revenue	-9.07%	-7.85%	-8.37%	-10.06%	-12.14%	-11.02%	-3.22%	-3.01%	-2.93%	-4.58%	-5.69%
Debt-free Net Working Capital to Revenue	2.72%	3.73%	8.45%	10.11%	4.29%	-2.75%	6.51%	8.61%	2.08%	-2.15%	-1.95%
Net Working Capital to Revenue	-2.14%	-4.04%	-0.15%	2.43%	2.34%	-11.11%	0.02%	-4.08%	-2.24%	-6.90%	-8.96%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.89)	($0.84)	($1.25)	($0.54)	$0.45	($1.44)	($2.82)	($3.07)	($2.18)	($2.48)	($1.01)
Adjusted Weighted Average Basic Shares Outstanding	227.53M	225.21M	190.46M	184.98M	183.50M	184.26M	186.60M	186.57M	185.45M	184.89M	183.50M
Adjusted Diluted Earnings per Share	($0.89)	($0.84)	($1.25)	($0.54)	$0.44	($1.44)	($2.82)	($3.07)	($2.18)	($2.48)	($1.01)
Adjusted Weighted Average Diluted Shares Outstanding	227.53M	225.21M	190.46M	184.98M	184.39M	184.26M	186.60M	186.57M	185.45M	184.89M	183.50M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	($1.44)	($2.82)	($3.07)	($2.18)	($2.48)	($1.01)
Adjusted Weighted Average Basic & Diluted Shares Outstanding	200.19M	189.34M	187.20M	185.58M	183.46M	185.91M	187.47M	186.16M	185.65M	184.33M	148.19M
Normalized Net Operating Profit after Tax (NOPAT)	39	16	-61	-136	6.86	5.71	-73	108	163	-16	-5.57
Normalized NOPAT Margin	1.23%	0.53%	-2.15%	-4.92%	0.19%	0.14%	-1.61%	2.27%	3.27%	-0.32%	-0.15%
Pre Tax Income Margin	-6.31%	-5.98%	-8.49%	-3.90%	2.47%	-6.67%	-12.75%	-12.39%	-8.02%	-11.09%	-8.63%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.21	0.18	-0.10	0.39	1.43	-0.09	-0.98	-0.71	-0.02	-0.40	-0.32
NOPAT to Interest Expense	0.12	0.05	-0.14	-0.77	-0.46	-0.12	-1.42	-0.56	-0.06	-0.29	-0.24
EBIT Less CapEx to Interest Expense	-0.90	-0.44	-1.03	1.19	-0.23	-0.92	-0.97	-1.15	-0.14	-1.31	-1.51
NOPAT Less CapEx to Interest Expense	-0.99	-0.57	-1.07	0.03	-2.12	-0.96	-1.42	-1.00	-0.18	-1.21	-1.43
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	22.12%	-8.92%	-0.81%	0.00%	-2.38%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Brookdale Senior Living's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	3.96%	3.51%	3.55%	3.56%	3.93%	7.69%	-0.02%	8.89%	11.13%	8.81%	18.05%
EBITDA Growth	8.40%	47.91%	9.71%	-19.73%	19.00%	-45.94%	-18.71%	146.52%	165.35%	276.07%	-65.09%
EBIT Growth	12.96%	111.37%	94.43%	-61.87%	161.99%	-165.82%	-81.92%	256.38%	120.07%	163.42%	-89.20%
NOPAT Growth	53.67%	91.17%	261.86%	-53.45%	146.05%	-194.35%	-133.00%	220.90%	114.61%	147.58%	129.93%
Net Income Growth	-119.71%	7.93%	-3.94%	-733.89%	33.62%	-255.42%	-72.03%	94.63%	55.45%	68.61%	-116.28%
EPS Growth	-115.38%	7.50%	0.00%	-750.00%	35.00%	-263.64%	-46.67%	95.56%	62.96%	71.79%	-116.85%
Operating Cash Flow Growth	2,142.06%	54.29%	45.22%	-12.78%	-104.77%	160.32%	-27.96%	451.30%	203.38%	40.33%	782.24%
Free Cash Flow Firm Growth	-189.96%	-209.28%	-181.58%	-72.24%	72.41%	-40.15%	469.28%	182.36%	-64.64%	710.81%	-132.12%
Invested Capital Growth	4.58%	4.64%	6.95%	-2.16%	-4.03%	-4.48%	-7.76%	-7.63%	-2.33%	-6.02%	2.43%
Revenue Q/Q Growth	4.21%	-0.41%	0.85%	-0.68%	3.76%	-0.37%	0.87%	-0.33%	7.52%	-7.51%	9.85%
EBITDA Q/Q Growth	25.76%	-2.56%	-7.35%	-4.52%	71.59%	-27.72%	-32.22%	41.57%	-22.05%	8.69%	105.55%
EBIT Q/Q Growth	1,066.48%	-71.99%	-52.55%	-27.15%	217.39%	-579.14%	-90.70%	400.60%	-70.51%	31.66%	180.46%
NOPAT Q/Q Growth	1,482.70%	-120.85%	-46.46%	-0.44%	179.41%	-282.41%	-115.40%	426.27%	-69.55%	33.76%	156.41%
Net Income Q/Q Growth	22.57%	-65.45%	-34.42%	-27.59%	67.55%	-86.78%	-978.46%	89.84%	-73.73%	9.60%	66.33%
EPS Q/Q Growth	24.32%	-68.18%	-29.41%	-30.77%	67.50%	-81.82%	-1,000.00%	90.00%	-81.82%	26.67%	66.67%
Operating Cash Flow Q/Q Growth	-48.22%	-31.99%	19.37%	4,957.77%	-103.91%	-35.99%	-28.30%	165.47%	149.51%	-176.45%	448.68%
Free Cash Flow Firm Q/Q Growth	12.51%	31.72%	-370.56%	-44.34%	6.28%	-49.03%	-7.92%	245.63%	-63.11%	414.49%	-170.41%
Invested Capital Q/Q Growth	0.39%	-3.12%	8.48%	-0.87%	0.45%	-0.98%	-0.77%	-2.76%	-0.03%	-4.38%	-0.62%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	95.85%	304.16%	25.27%	26.34%	26.10%	307.29%	24.42%	24.73%	24.89%	322.41%	25.67%
EBITDA Margin	15.28%	12.67%	12.95%	14.09%	14.66%	8.86%	12.22%	18.18%	12.80%	17.66%	15.03%
Operating Margin	3.63%	-0.27%	1.31%	2.46%	2.46%	-3.21%	-0.84%	5.48%	1.04%	3.67%	2.54%
EBIT Margin	3.66%	0.33%	1.16%	2.47%	3.37%	-2.98%	0.62%	6.71%	1.34%	4.87%	3.42%
Profit (Net Income) Margin	-7.99%	-10.75%	-6.47%	-4.85%	-3.78%	-12.08%	-6.45%	-0.60%	-5.92%	-3.66%	-3.75%
Tax Burden Percent	98.97%	104.43%	101.35%	101.20%	99.87%	112.06%	96.30%	106.47%	101.30%	98.19%	98.95%
Interest Burden Percent	-220.42%	-3,147.10%	-549.05%	-194.08%	-112.31%	362.12%	-1,080.98%	-8.44%	-436.98%	-76.53%	-110.59%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	1.92%	-0.14%	0.67%	1.29%	1.26%	-1.63%	-0.41%	2.64%	0.49%	1.65%	1.12%
ROIC Less NNEP Spread (ROIC-NNEP)	-0.27%	-2.28%	-0.83%	-0.11%	0.10%	-3.65%	-1.58%	1.76%	-0.85%	0.49%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-3.98%	-28.43%	-8.17%	-0.88%	0.79%	-27.08%	-12.11%	12.55%	-5.57%	2.85%	0.02%
Return on Equity (ROE)	-2.06%	-28.57%	-7.50%	0.42%	2.04%	-28.71%	-12.52%	15.19%	-5.08%	4.50%	1.14%
Cash Return on Invested Capital (CROIC)	-3.52%	-3.75%	-6.32%	2.32%	4.61%	4.90%	9.19%	9.45%	2.67%	5.52%	-4.35%
Operating Return on Assets (OROA)	1.97%	0.17%	0.61%	1.34%	1.80%	-1.56%	0.31%	3.29%	0.64%	2.23%	1.49%
Return on Assets (ROA)	-4.29%	-5.64%	-3.41%	-2.63%	-2.01%	-6.33%	-3.20%	-0.30%	-2.82%	-1.68%	-1.63%
Return on Common Equity (ROCE)	-2.05%	-28.44%	-7.47%	0.42%	2.04%	-28.62%	-12.48%	15.13%	-5.06%	4.49%	1.14%
Return on Equity Simple (ROE_SIMPLE)	-161.81%	0.00%	-71.44%	-60.93%	-46.55%	0.00%	-25.12%	-19.17%	-33.91%	0.00%	-59.93%
Net Operating Profit after Tax (NOPAT)	21	-1.50	7.18	13	13	-17	-4.44	29	5.48	18	13
NOPAT Margin	2.54%	-0.19%	0.92%	1.73%	1.72%	-2.25%	-0.59%	3.84%	0.73%	2.57%	1.77%
Net Nonoperating Expense Percent (NNEP)	2.19%	2.14%	1.50%	1.40%	1.16%	2.02%	1.17%	0.88%	1.34%	1.16%	1.11%
Return On Investment Capital (ROIC_SIMPLE)	0.45%	-0.03%	-	-	-	-0.38%	-	-	-	0.37%	-
Cost of Revenue to Revenue	4.15%	-204.16%	74.73%	73.66%	73.90%	-207.29%	75.58%	75.27%	75.11%	-222.41%	74.33%
SG&A Expenses to Revenue	74.32%	285.78%	5.73%	6.00%	5.84%	287.84%	5.69%	6.04%	6.45%	303.17%	5.46%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	92.21%	304.43%	23.96%	23.88%	23.64%	310.50%	25.25%	19.25%	23.85%	318.70%	23.14%
Earnings before Interest and Taxes (EBIT)	30	2.55	9.12	19	26	-22	4.69	50	10	34	26
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	124	99	102	110	115	67	93	137	96	124	114
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	8.54	4.72	4.57	3.87	3.33	2.71	1.58	1.48	1.02	0.88	1.62
Price to Tangible Book Value (P/TBV)	10.50	5.41	5.04	4.21	3.59	2.91	1.68	1.56	1.08	0.92	1.72
Price to Revenue (P/Rev)	0.40	0.32	0.43	0.43	0.41	0.36	0.26	0.27	0.19	0.18	0.29
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.27	1.19	1.24	1.25	1.22	1.18	1.08	1.07	1.01	0.99	1.08
Enterprise Value to Revenue (EV/Rev)	1.72	1.62	1.76	1.65	1.64	1.59	1.49	1.50	1.48	1.50	1.74
Enterprise Value to EBITDA (EV/EBITDA)	12.47	11.95	13.92	13.17	12.14	12.20	9.85	9.42	11.03	12.85	20.20
Enterprise Value to EBIT (EV/EBIT)	89.26	88.64	169.56	181.78	84.53	112.19	44.56	36.77	113.30	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	136.09	155.84	319.66	922.02	238.75	371.55	92.49	67.44	328.63	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	28.40	30.54	36.38	39.01	36.20	29.39	52.01	43.10	84.91	1,290.04	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	53.25	25.94	23.50	11.25	10.88	37.42	17.44	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	29.97	20.76	15.15	11.97	10.93	9.97	8.39	7.70	7.87	7.28	9.13
Long-Term Debt to Equity	28.85	20.05	14.46	11.21	10.23	9.40	7.39	7.25	7.38	6.86	8.69
Financial Leverage	14.96	12.44	9.79	8.29	8.10	7.41	7.68	7.15	6.56	5.84	5.84
Leverage Ratio	22.44	19.24	14.94	12.89	12.47	11.63	12.09	11.41	10.68	9.62	9.91
Compound Leverage Factor	-49.46	-605.42	-82.03	-25.02	-14.01	42.13	-130.70	-0.96	-46.69	-7.36	-10.96
Debt to Total Capital	96.77%	95.40%	93.81%	92.29%	91.62%	90.89%	89.35%	88.51%	88.73%	87.92%	90.13%
Short-Term Debt to Total Capital	3.62%	3.26%	4.26%	5.87%	5.85%	5.27%	10.69%	5.16%	5.54%	5.02%	4.40%
Long-Term Debt to Total Capital	93.15%	92.14%	89.55%	86.42%	85.77%	85.62%	78.66%	83.35%	83.19%	82.90%	85.73%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%
Common Equity to Total Capital	3.20%	4.56%	6.16%	7.68%	8.35%	9.08%	10.62%	11.46%	11.24%	12.05%	9.84%
Debt to EBITDA	10.22	10.45	11.36	10.66	10.00	10.30	9.21	8.83	10.93	12.91	18.88
Net Debt to EBITDA	9.58	9.59	10.51	9.74	9.11	9.41	8.11	7.73	9.61	11.30	16.85
Long-Term Debt to EBITDA	9.84	10.10	10.84	9.98	9.36	9.70	8.11	8.31	10.25	12.18	17.96
Debt to NOPAT	111.55	136.35	260.78	745.84	196.54	313.52	86.52	63.21	325.69	-142.29	-52.55
Net Debt to NOPAT	104.56	125.03	241.28	681.33	179.11	286.43	76.17	55.33	286.25	-124.53	-46.90
Long-Term Debt to NOPAT	107.38	131.68	248.95	698.39	183.99	295.35	76.17	59.52	305.37	-134.16	-49.99
Altman Z-Score	-0.30	-0.31	-0.29	-0.30	-0.29	-0.34	-0.36	-0.26	-0.33	-0.31	-0.29
Noncontrolling Interest Sharing Ratio	0.55%	0.47%	0.37%	0.34%	0.33%	0.31%	0.31%	0.36%	0.33%	0.29%	0.30%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.82	0.88	0.81	0.79	0.84	0.80	0.66	0.95	0.94	0.99	0.89
Quick Ratio	0.54	0.66	0.58	0.58	0.60	0.59	0.50	0.74	0.68	0.78	0.67
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-166	-190	-278	103	185	174	341	370	107	291	-92
Operating Cash Flow to CapEx	6.63%	28.48%	120.90%	122.60%	-2.63%	161.31%	70.67%	361.81%	48.37%	-102.14%	118.47%
Free Cash Flow to Firm to Interest Expense	-1.68	-2.16	-4.36	1.68	3.04	2.74	5.66	6.22	1.82	4.61	-1.69
Operating Cash Flow to Interest Expense	0.24	0.51	1.04	0.91	-0.02	0.46	0.76	1.07	0.41	-0.77	1.16
Operating Cash Flow Less CapEx to Interest Expense	-3.32	-1.29	0.18	0.17	-0.74	0.18	-0.32	0.77	-0.44	-1.53	0.18
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.54	0.52	0.53	0.54	0.53	0.52	0.50	0.49	0.48	0.46	0.43
Accounts Receivable Turnover	58.70	62.33	61.66	62.69	59.56	57.91	59.79	60.60	56.56	52.86	53.36
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.71	0.70	0.69	0.71	0.69	0.68	0.65	0.64	0.00	0.60	0.00
Accounts Payable Turnover	1.91	2.16	30.70	27.06	27.96	2.03	30.99	27.86	27.77	2.00	30.56
Days Sales Outstanding (DSO)	6.22	5.86	5.92	5.82	6.13	6.30	6.10	6.02	6.45	6.90	6.84
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	191.49	168.61	11.89	13.49	13.05	180.14	11.78	13.10	13.14	182.21	11.94
Cash Conversion Cycle (CCC)	-185.27	-162.76	-5.97	-7.67	-6.93	-173.84	-5.67	-7.08	-6.69	-175.30	-5.10
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	4,272	4,255	4,392	4,049	4,085	4,066	4,107	4,138	4,256	4,257	4,452
Invested Capital Turnover	0.76	0.75	0.73	0.75	0.73	0.72	0.69	0.69	0.67	0.64	0.63
Increase / (Decrease) in Invested Capital	187	189	285	-89	-171	-191	-346	-342	-102	-273	106
Enterprise Value (EV)	5,416	5,076	5,467	5,056	4,986	4,789	4,424	4,432	4,295	4,233	4,817
Market Capitalization	1,253	1,002	1,339	1,318	1,244	1,096	779	794	552	510	798
Book Value per Share	$0.73	$1.07	$1.49	$1.76	$1.66	$2.14	$2.61	$2.86	$2.88	$3.12	$2.63
Tangible Book Value per Share	$0.60	$0.93	$1.35	$1.62	$1.53	$2.00	$2.47	$2.71	$2.74	$2.97	$2.48
Total Capital	4,588	4,655	4,754	4,431	4,480	4,446	4,632	4,693	4,797	4,836	4,994
Total Debt	4,440	4,441	4,460	4,090	4,105	4,041	4,139	4,154	4,256	4,252	4,501
Total Long-Term Debt	4,274	4,289	4,257	3,829	3,843	3,807	3,644	3,912	3,991	4,009	4,282
Net Debt	4,162	4,072	4,126	3,736	3,741	3,692	3,644	3,636	3,741	3,721	4,018
Capital Expenditures (CapEx)	353	159	55	45	44	18	65	18	50	48	54
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-214	-284	-241	-223	-200	-237	-248	-257	-236	-237	-282
Debt-free Net Working Capital (DFNWC)	64	85	92	131	164	112	191	210	225	239	144
Net Working Capital (NWC)	-102	-67	-110	-129	-99	-122	-304	-32	-41	-4.11	-76
Net Nonoperating Expense (NNE)	86	82	58	51	43	74	44	33	50	44	42
Net Nonoperating Obligations (NNO)	4,123	4,041	4,098	3,707	3,709	3,661	3,613	3,599	3,715	3,673	3,959
Total Depreciation and Amortization (D&A)	95	96	92	90	88	89	88	86	86	90	88
Debt-free, Cash-free Net Working Capital to Revenue	-6.77%	-9.07%	-7.79%	-7.25%	-6.58%	-7.85%	-8.38%	-8.69%	-8.13%	-8.37%	-10.18%
Debt-free Net Working Capital to Revenue	2.04%	2.72%	2.97%	4.26%	5.38%	3.73%	6.44%	7.09%	7.75%	8.45%	5.20%
Net Working Capital to Revenue	-3.22%	-2.14%	-3.56%	-4.21%	-3.23%	-4.04%	-10.28%	-1.08%	-1.41%	-0.15%	-2.73%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.28)	($0.37)	($0.22)	($0.17)	($0.13)	($0.40)	($0.22)	($0.02)	($0.20)	($0.11)	($0.15)
Adjusted Weighted Average Basic Shares Outstanding	230.68M	227.53M	228.12M	226.79M	225.89M	225.21M	225.42M	225.40M	224.58M	190.46M	186.79M
Adjusted Diluted Earnings per Share	($0.28)	($0.37)	($0.22)	($0.17)	($0.13)	($0.40)	($0.22)	($0.02)	($0.20)	($0.11)	($0.15)
Adjusted Weighted Average Diluted Shares Outstanding	230.68M	227.53M	228.12M	226.79M	225.89M	225.21M	225.42M	225.40M	224.58M	190.46M	186.79M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	234.35M	200.19M	199.21M	197.20M	193.01M	189.34M	188.24M	188.22M	188.21M	187.20M	186.81M
Normalized Net Operating Profit after Tax (NOPAT)	22	2.64	7.84	13	15	4.71	1.92	3.77	5.48	-25	17
Normalized NOPAT Margin	2.70%	0.34%	1.00%	1.73%	1.87%	0.62%	0.25%	0.50%	0.73%	-3.62%	2.30%
Pre Tax Income Margin	-8.07%	-10.29%	-6.38%	-4.80%	-3.78%	-10.78%	-6.69%	-0.57%	-5.84%	-3.73%	-3.79%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.30	0.03	0.14	0.31	0.43	-0.35	0.08	0.85	0.17	0.54	0.47
NOPAT to Interest Expense	0.21	-0.02	0.11	0.22	0.22	-0.27	-0.07	0.48	0.09	0.29	0.25
EBIT Less CapEx to Interest Expense	-3.26	-1.78	-0.72	-0.43	-0.28	-0.64	-1.00	0.55	-0.67	-0.21	-0.51
NOPAT Less CapEx to Interest Expense	-3.35	-1.82	-0.75	-0.52	-0.49	-0.55	-1.15	0.19	-0.75	-0.47	-0.73
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Brookdale Senior Living's Financials

When does Brookdale Senior Living's financial year end?

According to the most recent income statement we have on file, Brookdale Senior Living's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Brookdale Senior Living's net income changed over the last 10 years?

Brookdale Senior Living's net income appears to be on a downward trend, with a most recent value of -$201.99 million in 2024, rising from -$149.43 million in 2014. The previous period was -$189.07 million in 2023. See Brookdale Senior Living's forecast for analyst expectations on what’s next for the company.

What is Brookdale Senior Living's operating income?

Brookdale Senior Living's total operating income in 2024 was $46.53 million, based on the following breakdown:

Total Gross Profit: $2.98 billion
Total Operating Expenses: $2.94 billion

How has Brookdale Senior Living revenue changed over the last 10 years?

Over the last 10 years, Brookdale Senior Living's total revenue changed from $3.83 billion in 2014 to $3.13 billion in 2024, a change of -18.4%.

How much debt does Brookdale Senior Living have?

Brookdale Senior Living's total liabilities were at $6.12 billion at the end of 2024, a 18.4% increase from 2023, and a 18.8% decrease since 2014.

How much cash does Brookdale Senior Living have?

In the past 10 years, Brookdale Senior Living's cash and equivalents has ranged from $88.03 million in 2015 to $398.85 million in 2022, and is currently $308.93 million as of their latest financial filing in 2024.

How has Brookdale Senior Living's book value per share changed over the last 10 years?

Over the last 10 years, Brookdale Senior Living's book value per share changed from 15.71 in 2014 to 1.07 in 2024, a change of -93.2%.

Related Companies

This page (NYSE:BKD) was last updated on 5/22/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Brookdale Senior Living (BKD) Financials

Frequently Asked Questions About Brookdale Senior Living's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Brookdale Senior Living (BKD) Financials

Annual Income Statements for Brookdale Senior Living

Quarterly Income Statements for Brookdale Senior Living

Annual Cash Flow Statements for Brookdale Senior Living

Quarterly Cash Flow Statements for Brookdale Senior Living

Annual Balance Sheets for Brookdale Senior Living

Quarterly Balance Sheets for Brookdale Senior Living

Annual Metrics And Ratios for Brookdale Senior Living

Quarterly Metrics And Ratios for Brookdale Senior Living

Frequently Asked Questions About Brookdale Senior Living's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools